SOURCE: IN3 Medical Device 360 Conferences
DUBLIN, IRELAND--(Marketwired - Feb 20, 2014) - 'Investment in Innovation (IN3) Medical Device 360° Dublin', the medtech industry's leading partnering event being held April 8-10, 2014 at The Shelbourne in Dublin, Ireland, will be hosting MedTech Idol Dublin 2014, a new kind of venture competition produced by RCT Ventures.
Send in your application by February 24th to expose your start-up to medical device investors and VCs focused on medical device investing. The judging panel, which includes Alan O'Connell, Partner at Seroba Kernel, Tim Haines, Partner at Abingworth, Antoine Papiernik, Managing Partner at Sofinnova Partners, and Paul Grand, Managing Director at RCT Ventures and Master of Ceremonies, will choose 10 semi-finalists to receive complimentary registration to attend IN3 Medical Device 360° Dublin. The semi-finalists will compete to be among 4 Finalists who will present on-stage during the live competition. The audience will then vote in real-time for the winner. The winner will get a complimentary presenting slot and registration to Investment in Innovation (IN3) Medical Device 360° Summit in San Francisco, November 5-7, 2014, and will be profiled in an upcoming issue of the monthly magazine "START-UP" which reviews emerging medical ventures.
IN3 Medical Device 360° Dublin will also feature presentations by 40 early-, mid- and late-stage start-up companies seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. Presenting companies to date include Aerogen, Inc., Anagnostics Bioanalysis GmbH, Autonomic Technologies Inc., Dimicron, Inc., DMF Medical, Inc., Embo Medical, Emperra, Functional Neuromodulation, Inc., Human.technology Styria GmbH, Humedics GmbH, Implandata Ophthalmic Products GmbH, Keystone Heart Ltd., Knowledge GmbH, LIM Innovations, Miracor Medical Systems GmbH, Nasseo, Inc., Neuravi Ltd., Novate Medical Ltd., PQ Bypass, Quanta Fluid Solutions, Seiratherm GmbH, Senzime, ThermopeutiX, Inc., Transcatheter Technologies GMGH, Zydacron, and Zyomyx, Inc.
Participating Corporate Acquirers and Investors Include: Apposite Capital, Bay City Capital LLC, Cook Medical, Covidien, Medtronic, Earlybird Venture Capital, Endeavour Vision, Enterprise Equity Venture Capital Group, LSP Health Economics Fund, MVM Life Science Partners LLP, MVM Life Science Partners LLP, Seroba Kernel, Seventure Partners, Sorin Group and VI Partners.
This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2014 and beyond. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.
Emerging medtech companies that would like to apply to present in Dublin should contact Kayleen Kell at firstname.lastname@example.org.
Event sponsors include Enterprise Ireland, Seroba Kernel, KPMG, Medmarc, Eugene F. Collins, XMS Capital Partners, Bank of Ireland, Creganna Tactx Medical, Medpace, MassMEDIC, OneMedPlace, Eucomed and Marketwired.
Visit www.in3dublin.com for full conference and registration details.
About IN3 Medical Device 360° Conferences
Investment-In-Innovation (IN3) Medical Device 360° Conferences have been regarded as one of the most exceptional medical device partnering events for the past 14 years. The conferences highlight early-to late state companies looking to meet and network with potential investors from the healthcare investment firms, to larger top-tier medical device companies for the purpose of funding, M&A, or strategic partnership. International industry experts discuss the most pressing issues during a variety of financing, business development, clinical/regulatory, reimbursement and emerging market panel discussions, presentations and networking sessions.